Asthma control in elderly asthmatics. An Italian observational study

Respir Med. 2014 Aug;108(8):1091-9. doi: 10.1016/j.rmed.2014.05.016. Epub 2014 Jun 9.

Abstract

Background: The exponential increase of individuals aged >64 yrs is expected to impact the burden of asthma. We aimed to explore the level of asthma control in elderly subjects, and factors influencing it.

Methods: A multicenter observational study was performed on consecutive patients >64 years old with a documented physician-diagnosis of asthma. Sixteen Italian centers were involved in this 6-month project.

Findings: A total of 350 patients were enrolled in the study. More than one-third of elderly asthmatic patients, despite receiving GINA step 3-4 antiasthmatic therapy, had an Asthma Control Test score ≤19, with a quarter experiencing at least one severe asthma exacerbation in the previous year. Twenty-nine percent of patients (n = 101) were classified as having Asthma-COPD Overlap Syndrome (ACOS) due to the presence of chronic bronchitis and/or CO lung diffusion impairment. This subgroup of patients had lower mean Asthma Control Test scores and more exacerbations compared to the asthmatic patients (18 ± 4 compared to 20 ± 4, p < 0.01, and 43% compared to 18%, p < 0.01, respectively). Modified Medical Research Council dyspnea mMRC scores and airway obstruction, assessed on the basis of a FEV(1)/FVC ratio below the lower limit of normal, were more severe in ACOS than in asthma, without any difference in responses to salbutamol. In a multivariate analysis, the mMRC dyspnea score, FEV(1)% of predicted and the coexistence of COPD were the only variables to enter the model.

Interpretation: Our results highlight the need to specifically evaluate the coexistence of features of COPD in elderly asthmatics, a factor that worsens asthma control.

Keywords: Asthma; Asthma control test; Elderly.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / complications
  • Asthma / physiopathology
  • Asthma / prevention & control*
  • Female
  • Forced Expiratory Volume / physiology
  • Humans
  • Male
  • Pulmonary Disease, Chronic Obstructive / complications
  • Treatment Outcome
  • Vital Capacity / physiology

Substances

  • Anti-Asthmatic Agents